Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
<strong><em>Objective(s):</em></strong> Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorod...
Main Authors: | Ismet Sarikaya, Ali Sarikaya, Ahmed Albatineh, Ebru Tastekin, Yavuz Sezer |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2020-01-01
|
Series: | Asia Oceania Journal of Nuclear Medicine and Biology |
Subjects: | |
Online Access: | http://aojnmb.mums.ac.ir/article_14081_7ad38e1b531b95c22a1addd74d7a6326.pdf |
Similar Items
-
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
by: Ezra Hahn, et al.
Published: (2023-06-01) -
Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01) -
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01) -
Is palpable DCIS more aggressive than screen-detected DCIS?
by: Nina Balac, et al.
Published: (2023-01-01) -
Effect of various blood glucose levels on regional FDG uptake in the brain
by: Ismet Sarikaya, et al.
Published: (2020-01-01)